In response to a need for a Chain of Identity (CoI) Identifier when more than one donation may be required to manufacture or deliver a given therapy, ICCBBA published the ISBT 128 Standard Chain of Identity (CoI) Identifier (ST-028) in December 2022.
Since that time, the new data structure has been implemented at many sites to document and maintain the chain of custody for patient-specific cell therapy manufacturing. An implementation guide has now been drafted to provide guidance on how the CoI Identifier can be utilized in various scenarios. ICCBBA is soliciting public comment to further strengthen the usefulness of the draft implementation guide.
We encourage your participation in the public comment period. The authors have requested comments to be submitted by November 20, 2024.
Comments should be directed to IG050@isbt128.org.